.Pharmacolibrary.Drugs.V_Various.V08C_MagneticResonanceImagingContrastMedia.V08CX01_Perflubron.Perflubron .Pharmacolibrary.Drugs.V_Various.V08C_MagneticResonanceImagingContrastMedia.V08CX01_Perflubron.Perflubron| name: | Perflubron | |
| ATC code: | V08CX01 | route: | intravenous |
| compartments: | 1 | |
| dosage: | 3400 | mg |
| volume of distribution: | 0.13 | L |
| clearance: | 0.11 | mL/min/kg |
| other parameters in model implementation | ||
Perflubron (perfluorooctyl bromide) is a radiocontrast agent formerly used in diagnostic imaging, particularly as a contrast medium for magnetic resonance imaging (MRI) and computed tomography (CT). It is a fluorinated, inert compound that enhances imaging quality. Perflubron is no longer widely approved or used in current practice.
No published peer-reviewed pharmacokinetic studies are available for perflubron as an imaging agent in humans; pharmacokinetic parameters below are estimated based on animal studies, the physicochemical properties of perfluorocarbon compounds, and limited human imaging reports.